Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Berkshire Hathaway B BRK-B Nov 7, 2025 499.06 +1.20   
 Best Buy BBY Nov 7, 2025 79.03 +0.46   
 Bio-Techne TECH Nov 7, 2025 57.41 -1.32   
 Biogen BIIB Nov 7, 2025 155.51 -0.78   
 BlackRock BLK Nov 7, 2025 1 082.20 +1.19   
 Blackstone BX Nov 7, 2025 145.94 +1.75   
 Block A XYZ Nov 7, 2025 65.45 -7.73   
 Boeing BA Nov 7, 2025 194.61 -0.96   
 Booking BKNG Nov 7, 2025 4 940.00 +0.84   
 Boston Properties BXP Nov 7, 2025 72.36 +3.22   
 Boston Scientific BSX Nov 7, 2025 100.02 +0.98   
 Bristol-Myers Squibb BMY Nov 7, 2025 46.69 +0.13   
 Broadcom AVGO Nov 7, 2025 349.43 -1.73   
 Broadridge Financial Solutions BR Nov 7, 2025 221.72 +1.94   
 Brown & Brown BRO Nov 7, 2025 78.54 +2.77   
 Brown Forman B BF-B Nov 7, 2025 26.60 +0.26   
 Builders Firstsource BLDR Nov 7, 2025 109.42 +0.35   
 Bunge BG Nov 7, 2025 94.72 -0.05   
 C.H. Robinson Worldwide CHRW Nov 7, 2025 149.44 +0.82   
 Cadence Design Systems CDNS Nov 7, 2025 325.05 +0.18   
 Caesars Entertainment CZR Nov 7, 2025 19.82 +3.44   
 Camden Property Trust CPT Nov 7, 2025 101.78 +2.51   
 Campbell Soup CPB Nov 7, 2025 30.74 +2.26   
 Capital One Financial COF Nov 7, 2025 217.82 +0.43   
 Cardinal Health CAH Nov 7, 2025 203.67 +2.87   
 CarMax KMX Nov 7, 2025 32.36 +4.79   
 Carnival CCL Nov 7, 2025 26.73 +1.37   
 Carrier Global CARR Nov 7, 2025 57.51 +1.66   
 Caterpillar CAT Nov 7, 2025 563.10 -1.17   
 CBOE Holdings CBOE Nov 7, 2025 256.62 +1.58   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.